Globe and Mail article: Linking real-time ultrasound to MRI may aid prostate cancer assessment
CIMTEC's Chief Scientific Officer and Centre Director, Dr. Aaron Fenster, is quoted in the Globe and Mail about the effectiveness of new ultrasound fusion technologies to greatly improve biopsy and treatment of prostate cancer. CIMTEC is working with several companies that are developing such technologies.